Assessment of platelet function in patients with stroke using multiple electrode platelet aggregometry: a prospective observational study
Stanford, Sophia N.
Potter, John F.
Evans, Phillip A.
MetadataShow full item record
Background There is a link between high on-treatment platelet reactivity (HPR) and adverse vascular events in stroke. This study aimed to compare multiple electrode platelet aggregometry (MEA), in healthy subjects and ischaemic stroke patients, and between patients naive to antiplatelet drugs (AP) and those on regular low dose AP. We also aimed to determine prevalence of HPR at baseline and at 3–5 days after loading doses of aspirin. Methods Patients with first ever ischaemic stroke were age and sex-matched to a healthy control group. Three venous blood samples were collected: on admission before any treatment given (baseline); at 24 h and 3–5 days after standard treatment. MEA was determined using a Mutliplate® analyser and agonists tested were arachidonic acid (ASPI), adenosine diphosphate (ADP) and collagen (COL). Results Seventy patients (mean age 73 years [SD 13]; 42 men, 28 women) were age and sex-matched to 72 healthy subjects. Thirty-three patients were on antiplatelet drugs (AP) prior to stroke onset and 37 were AP-naive. MEA results for all agonists were significantly increased in AP-naive patients compared to healthy subjects: ADP 98 ± 31 vs 81 ± 24, p < 0.005; ASPI 117 ± 31 vs 98 ± 27, p < 0.005; COL 100 ± 25 vs 82 ± 20, p < 0.005. For patients on long term AP, 33% (10/30) of patients were considered aspirin-resistant. At 3–5 days following loading doses of aspirin, only 11.1% were aspirin resistant based on an ASPI cut-off value of 40 AU*min. Conclusions Many patients receiving low dose aspirin met the criteria of aspirin resistance but this was much lower at 3–5 days following loading doses of aspirin. Future studies are needed to establish the causes of HPR and potential benefits of individualizing AP treatment based on platelet function testing.
Sabra, A., Stanford, S.N., Storton, S., Lawrence, M., D’Silva, L., Morris, R.H.K., Evans, V., Wani, M., Potter, J.F. and Evans, P.A., (2016) 'Assessment of platelet function in patients with stroke using multiple electrode platelet aggregometry: a prospective observational study', BMC neurology, 16(1), p.254.
This article was published in BMC Neurology on 9 December 2016 (online), available open access at http://dx.doi.org/10.1186/s12883-016-0778-x
Cardiff Metropolitan University (Grant ID: Cardiff Metropolian (Internal))
Showing items related by title, author, subject and abstract.
The changes in clot microstructure in patients with ischaemic stroke and the effects of therapeutic intervention: a prospective observational study Stanford, Sophia N.; Sabra, Ahmed; D'Silva, Lindsay; Lawrence, Matthew; Morris, Keith; Storton, Sharon; Brown, Martin R.; Evans, Vanessa; Hawkins, Karl; Williams, Phylip Rhodri; Davidson, Simon J.; Wani, Mushtaq; Potter, John F.; Evans, Phillip A. (BioMed Central, 2015-03-15)Background Stroke is the second largest cause of death worldwide. Hypercoagulability is a key feature in ischaemic stroke due to the development of an abnormally dense clot structure but techniques assessing the mechanics ...
Al-Ketheree, Zainab A.N. (Cardiff Metropolitan University, 2004)Sensitivity to aspirin, non-steroidal anti-inflammatory drugs (NSAIDs) and also dietary salicylate is an increasingly important and observed phenomenon. The reliable diagnosis of individuals with these disorders is of great ...
Changes in platelet function independent of pharmacotherapy following coronary intervention in non-ST-elevation myocardial infarction patients Freeman, Phillips M.; Moschonas, Konstantinos E.; Hinz, Christine; O'Donnell, Valerie B.; Kinnaird, Tim D.; James, Philip; Anderson, Richard A. (Elsevier, 2015)Background High on treatment platelet reactivity (HTPR) is common in patients receiving clopidogrel following an acute coronary syndrome (ACS); it's also associated with increased morbidity and mortality. More potent and ...